Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 8418.T
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 855.31 2.13 0.22
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 1506.81 624.72 -38.88
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 5.42 3002.09 2847.83
Cash -11.85 6378.14 7235.21
Capex 0.00 0.00 0.00
Free Cash Flow inf 0.00 9.78
Revenue 22.36 213.56 174.53
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin 0.00 1.00 1.00
Operating Margin -63.72 0.11 0.32
ROA -55.00 < 0.005 < 0.005
ROE -56.90 < 0.005 0.01
ROIC -38.77 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 8418.T is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 8418.T is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 8418.T is permitted for members.